Skip to main content

Table 4 The outcome of the arterial blood gas analysis in both groups

From: Comparison of the efficacy and safety of sedation protocols with the use of dexmedetomidine–remifentanil and propofol–remifentanil during percutaneous closure of atrial septal defects: a randomized clinical trial

 

D–R group (n = 29)

P–R group (n = 30)

Difference (95% CI)

P value

Baseline

    

 pH

7.42 ± 0.02

7.42 ± 0.03

− 0.002 (− 0.013 to 0.009)

0.722

 PaO2 (mmHg)

79.2 ± 4.43

80.33 ± 6.11

− 1.12 (− 3.92 to 1.66)

0.422

 PaCO2 (mmHg)

35.8 ± 3.30

35.70 ± 4.24

0.13 (− 1.86 to 2.11)

0.898

At the end of the procedure

    

 PH

7.36 ± 0.02

7.34 ± 0.02

0.017 (0.006 to 0.029)

0.003

 PaO2 (mmHg)

130.03 ± 4.99

125.70 ± 7.01

4.33 (1.15 to 7.52)

0.008

 PaCO2 (mmHg)

41.52 ± 4.22

44.70 ± 5.31

− 3.18 (− 5.68 to − 0.69)

0.013

Hypercapnia, n (%)

4 (13.8%)

13 (43.3%)

29.5% (7.8 to 51.2%)

0.012

  1. D–R group: dexmedetomidine–remifentanil group; P–R group: propofol–remifentanil group; PH: pondus hydrogenii; PaO2: partial pressure of oxygen; PaCO2: partial pressure of carbon dioxide